Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adempas in Sickle Cell Disease
NCT02633397Phase 2Completed
- Start
- Apr 2017
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of riociguat in sickle cell disease (SCD). Started Apr 2017; status: completed.
02
Drugs
riociguat
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02633397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633397.